Loader

Pathways

PathWhiz ID Pathway Meta Data

PW176248

Pw176248 View Pathway
metabolic

Chlorpropamide Predicted Metabolism Pathway

Homo sapiens
Metabolites of Chlorpropamide are predicted with biotransformer.

PW128178

Pw128178 View Pathway
drug action

Chlorprothixene Dopamine Antagonist Action Pathway

Homo sapiens
Chlorprothixene is a thioxanthene antipsychotic. Chlorprothixene blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis.

PW145325

Pw145325 View Pathway
drug action

Chlorprothixene Drug Metabolism Action Pathway

Homo sapiens

PW176648

Pw176648 View Pathway
drug action

Chlorprothixene H1 Antihistamine Smooth Muscle Relaxation Action Pathway

Homo sapiens
Chlorprothixene is a typical antipsychotic drug of the thioxanthene (tricyclic) class. Chlorprothixene exerts strong blocking effects by blocking the 5-HT2 D1, D2, D3, histamine H1, muscarinic and alpha1 adrenergic receptors. H1-antihistamines interfere with the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria. H1-antihistamines act on H1 receptors in T-cells to inhibit the immune response, in blood vessels to constrict dilated blood vessels, and in smooth muscles of lungs and intestines to relax those muscles. Allergies causes blood vessel dilation which causes swelling (edema) and fluid leakage. Chlorprothixene also inhibits the H1 histamine receptor on bronchiole smooth muscle myocytes. This normally activates the Gq signalling cascade which activates phospholipase C which catalyzes the production of Inositol 1,4,5-trisphosphate (IP3) and Diacylglycerol (DAG). Because of the inhibition, IP3 doesn't activate the release of calcium from the sarcoplasmic reticulum, and DAG doesn't activate the release of calcium into the cytosol of the endothelial cell. This causes a low concentration of calcium in the cytosol, and it, therefore, cannot bind to calmodulin. Calcium bound calmodulin is required for the activation of myosin light chain kinase. This prevents the phosphorylation of myosin light chain 3, causing an accumulation of myosin light chain 3. This causes muscle relaxation, opening up the bronchioles in the lungs, making breathing easier.

PW176741

Pw176741 View Pathway
drug action

Chlorprothixene H1-Antihistamine Blood Vessel Constriction Action Pathway

Homo sapiens
Chlorprothixene is a typical antipsychotic drug of the thioxanthene (tricyclic) class. Chlorprothixene exerts strong blocking effects by blocking the 5-HT2 D1, D2, D3, histamine H1, muscarinic and alpha1 adrenergic receptors. Chlorprothixene inhibits the H1 histamine receptor on blood vessel endothelial cells. This normally activates the Gq signalling cascade which activates phospholipase C which catalyzes the production of Inositol 1,4,5-trisphosphate (IP3) and Diacylglycerol (DAG). Because of the inhibition, IP3 doesn't activate the release of calcium from the sarcoplasmic reticulum, and DAG doesn't activate the release of calcium into the cytosol of the endothelial cell. This causes a low concentration of calcium in the cytosol, and it, therefore, cannot bind to calmodulin. Calcium bound calmodulin is required for the activation of the calmodulin-binding domain of nitric oxide synthase. The inhibition of nitric oxide synthesis prevents the activation of myosin light chain phosphatase. This causes an accumulation of myosin light chain-phosphate which causes the muscle to contract and the blood vessel to constrict, decreasing the swelling and fluid leakage from the blood vessels caused by allergens.

PW176496

Pw176496 View Pathway
metabolic

Chlorprothixene Predicted Metabolism Pathway

Homo sapiens
Metabolites of Chlorprothixene are predicted with biotransformer.

PW128189

Pw128189 View Pathway
drug action

Chlorprothixene Serotonin Antagonist Action Pathway

Homo sapiens
Chlorprothixene is a thioxanthene antipsychotic. Chlorprothixene blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis.

PW146644

Pw146644 View Pathway
drug action

Chlorquinaldol Drug Metabolism Action Pathway

Homo sapiens

PW128373

Pw128373 View Pathway
drug action

Chlortetracycline Action Pathway

Homo sapiens
Chlortetracycline is a tetracycline antibiotic commonly used for veterinary practice, that is commonly administered via topical ointment. Chlortetracycline acts by competing for the A site of the bacterial ribosome, by doing so the tRNA cannot bind to the site and thus no more amino acids cannot be added to the peptide chain. Ultimately leading to protein synthesis and halting growth and reproduction, as proteins cannot be synthesized that are necessary for bacteria cell reproduction.

PW145973

Pw145973 View Pathway
drug action

Chlortetracycline Drug Metabolism Action Pathway

Homo sapiens